About Amy Abernethy
Amy Abernethy is a cofounder, highlander health and director at Georgiamune.
Experience
This experience comes from Amy Abernethy's profile and from SEC filings. For roles taken from filings, the years are when the filings name Amy Abernethy in the role, so the role may have started earlier or lasted longer.
PH
Pedestal Health Current
Co-CEO
2026 – Present
OF
One Health / FidoCure Current
Director
2025 – Present
HH
Highlander Health Current
Cofounder
2024 – Present
IN
insitro Current
Director
2024 – Present
Georgiamune, Inc. Current
Cofounder, Highlander Health and director
2021 – Present · Gaithersburg, MD
Develops immune-based drugs for people with cancer and autoimmune diseases.
DU
Duke University Current
Board of Trustees (2024 – Present)
Professor of Medicine (and related progressive roles) (2001 – 2015)
2001 – Present
SS
Sixth Street
Scientific Advisory Board
2022 – 2026
VS
Verily Life Sciences
President, Product Development & Chief Medical Officer, Verily
2021 – 2024
EQ
EQRx
Director
2021 – 2023
CI
CM Life Sciences III
Director
2021
UA
US Food & Drug Administration
Principal Deputy Commissioner & Acting CIO
2019 – 2021
CI
CareDx, Inc.
Director
2018 – 2019
PC
Pappas Capital
Scientific Advisory Board
2017 – 2019
FH
Flatiron Health
Chief Medical Officer/Chief Scientific Officer & SVP Oncology
2014 – 2019
AI
athenahealth, Inc
Director
2013 – 2019
DC
Duke Center for Learning Health Care
Director
2012 – 2015
Key Colleagues at Startups
The people Amy Abernethy works with at each company, as listed on that company's latest Form D.
Georgiamune, Inc. · Form D, Aug 17, 2026
Sean Parker
Chairman, Parker Institute for Cancer Immunotherapy
EV
Elena Viboch
Director
Fredrick Schaufeld
Director
Paul Brown
Cofounder, CEO, Inspire Brand and director
NO
Nancy Ondovik
Director
Samir Khleif
Founder/President/Chief Executive Officer and director